Company · founded 2001
Cellerant Therapeutics (United States)
San Carlos, United States · cellerant.com
- Citations, last 5 years
- 3
- Works, last 5 years
- 2
- h-index
- 23
- Scientists listed
- 0
- Grants since 2016
- 2
Grants received
2016–2018 · contract · N44
IGF::OT::IGF: SBIR PHASE II, TOPIC 326: DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS
Jagath Junutula · Cellerant Therapeutics (United States) · funded by National Institutes of Health
2013–2020 · research · R42
Novel Indication for Myeloid Progenitor Use: Induction of Tolerance in Solid Organ Transplantation
Adrianus G.W. Domen · Cellerant Therapeutics (United States) · funded by National Institutes of Health
